Dose Escalation Study of EM-1421 for the Treatment of Recurrent or Refractory Solid Tumors
Clinical trial NCT00259818 · COMPLETED
Trial details
- NCT number
- NCT00259818
- Sponsor
- Erimos Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.